Zhangzhou Jiulongjiang is a local government-owned entity based in China's Zhangzhou city. The company primarily engages in the manufacture of proprietary Chinese medicine (60% of gross profit in 2022) and bearings (6%), with asset management (23%) and other activities (11%) rounding up the portfolio.